Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review
Open Access
- 28 January 2022
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (4) , 794-805
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Results of clot waveform analysis and thrombin generation test for a plasma‐derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors—phase I trial: 2nd reportHaemophilia, 2012
- Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII – an open label, exploratory, cross‐over, phase I/II studyHaemophilia, 2010
- Early long‐term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case seriesHaemophilia, 2009
- Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIaEuropean Journal of Clinical Investigation, 2009
- The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agentsInternational Journal of Laboratory Hematology, 2009
- Thrombin generation assay: a useful routine check‐up tool in the management of patients with haemophilia?Haemophilia, 2009
- Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia APlatelets, 2006
- Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIaPlatelets, 2005
- Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and BThrombosis and Haemostasis, 2005
- Monitoring the bioavailability of FEIBA with a thrombin generation assayJournal of Thrombosis and Haemostasis, 2003